QCM
RXST icon

Quantinno Capital Management’s RxSight RXST Stock Holding History

Quantinno Capital Management’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$88.4K Sell
14,357
-8,450
-37% -$70.2K ﹤0.01% 3265
2025
Q4 		$238K Buy
22,807
+4,642
+26% +$46.6K ﹤0.01% 2969
2025
Q3 		$163K Buy
18,165
+8,165
+82% +$71.7K ﹤0.01% 2812
2025
Q2 		$130K Buy
+10,000
New +$150K ﹤0.01% 2462

Other funds holding RXST

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
NSGL
No Street GP LP San Francisco, California $1.5B AUM 34.53% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Quantinno Capital Management's RXST Position: Q1 2026 in Review

Quantinno Capital Management reduced its RxSight (RXST) stake by 37% in Q1 2026, selling an estimated $70.2K and leaving 14,357 shares worth $88.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3265.

Quantinno Capital Management first reported a position in RXST in Q2 2025 and has held it in 4 quarters since. The position peaked at $238K in Q4 2025. 164 funds tracked by Wall St. Rank hold RXST as of Q1 2026.

  • Quantinno Capital Management held 14,357 shares of RxSight worth $88.4K as of Q1 2026.
  • Quantinno Capital Management sold 8,450 RxSight shares in Q1 2026, an estimated $70.2K.
  • RxSight made up ﹤0.01% of Quantinno Capital Management's portfolio in Q1 2026, its #3265 holding.
  • Quantinno Capital Management first reported a position in RxSight in Q2 2025 and has held it in 4 quarters since.
  • Quantinno Capital Management's RxSight position peaked at $238K in Q4 2025.
  • 164 funds tracked by Wall St. Rank held RxSight as of Q1 2026.

Based on Quantinno Capital Management's 13F filing for Q1 2026, filed 15 May 2026.